Invesaro

Stocks Consumer discretionary HAO

NASDAQ · Consumer discretionary

Haoxi Health Technology Ltd (HAO)

Haoxi Health Technology Ltd reported revenue of $32.8M in fiscal 2025, down 32.4% from a year earlier. Net income was $3.9M, a net margin of 11.8%. At June 30, 2025 it held $8.6M in cash against $607.7K of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on October 20, 2025.

Revenue (FY2025)
$32.8M
-32.4% year on year
Net margin
11.8%

What Haoxi Health Technology Ltd does

Haoxi Health Technology Ltd is registered with the SEC under industry code SIC 7311 (Services-Advertising Agencies). Its shares trade on NASDAQ under the ticker HAO.

Revenue and profit by year

Revenue
FY22: $16.2M $16.2M FY22FY24: $28.2M $28.2M FY24FY24: $48.5M $48.5M FY24FY25: $32.8M $32.8M FY25
Net income
FY22: $244.6K $244.6K FY22FY24: $969.8K $969.8K FY24FY24: $1.3M $1.3M FY24FY25: $3.9M $3.9M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$32.8M-$2M$3.9M$1.32n/a
2024$48.5M$1.7M$1.3M$1.06-$802.9K
2024$28.2M$1.2M$969.8K$0.87-$917.6K
2022$16.2M$268.8K$244.6K$0.22-$684.1K

Full financial statements: income, balance sheet and cash flow

Where HAO ranks in Consumer discretionary

Revenue$32.8M
#793 of 955 in Consumer discretionary · Bottom 17%
Revenue growth-32.4%
#868 of 887 in Consumer discretionary · Bottom 2%
Net margin11.8%
#157 of 901 in Consumer discretionary · Top 17%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer discretionary

Latest SEC filings

What Haoxi Health Technology Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. July 13, 2026
  2. July 13, 2026
  3. July 6, 2026
  4. June 24, 2026
  5. June 4, 2026
  6. May 21, 2026
  7. May 19, 2026
  8. May 13, 2026
  9. May 12, 2026
  10. April 22, 2026

Recent insider filings (Forms 3, 4 and 144): 7, the latest on May 20, 2026. Insider transactions on SEC

Insider trades

What the people running Haoxi Health Technology Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
May 19, 2026 Fan ZhenCEO & Chairman, Director, 10% owner Bought 40,000,000 $0.02 $720K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns HAO

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 40,690,800 shares in total.

HolderSharesAs of
Fan ZhenCEO & Chairman, Director, 10% owner 40,690,800 May 19, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about HAO

What does Haoxi Health Technology Ltd do?

Haoxi Health Technology Ltd is registered with the SEC under industry code SIC 7311 (Services-Advertising Agencies). Its shares trade on NASDAQ under the ticker HAO.

Is Haoxi Health Technology Ltd profitable?

Yes. In fiscal 2025 it reported net income of $3.9M on revenue of $32.8M, a net margin of 11.8%.

How much revenue does Haoxi Health Technology Ltd make?

In fiscal 2025 Haoxi Health Technology Ltd reported revenue of $32.8M. That is 32.4% less than a year earlier.

When did Haoxi Health Technology Ltd last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on October 20, 2025. It covers the period to June 30, 2025. Its newest filing of any kind is the foreign issuer update from July 13, 2026.

Similar companies

Compare HAO with

Compare HAO with any company

Follow HAO

Get an email when Haoxi Health Technology Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Follow HAO: get an email when it files

Where the numbers come from

Financial figures are the values Haoxi Health Technology Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.